Invenra Raises $2M
Biotech company Invenra announced recently that it raised more than $2 million dollars from investors. According to Vice President Mark Kubik, the funds will be used primarily for working capital…
Biotech company Invenra announced recently that it raised more than $2 million dollars from investors. According to Vice President Mark Kubik, the funds will be used primarily for working capital…
Chalk up another healthcare system and state for Cologuard. Exact Sciences announced Wednesday that Kentucky-based Norton Healthcare is offering the colorectal cancer screen test to its patients. “Norton Healthcare’s adoption…
Cellular Dynamics International announced last week that it has entered into an agreement with the Cord Blood Registry to reprogram its newborn stem cells into pluripotent stem cells. According to…
SHINE Medical Technologies today announced a development and supply agreement with Middleton-based Phoenix Nuclear Labs. SHINE will provide funding for Phoenix Nuclear Labs to refine its neutron generator technology. In…
The Wisconsin Economic Development Corporation today announced it will help fund a joint venture between the University of Wisconsin School of Medicine and Public Health and Swoop Search LLC called…
Exact Sciences today announced it will sell 4 million shares of its common stock at $25.75 per share until Friday. According to a release, the company intends to use the…
The U.S. Department of Energy’s National Nuclear Security Administration awarded SHINE Medical Technologies $3.28 million as part of a a $6.6 million cooperative agreement, the company announced Monday. According to…
The Nancy Lurie Marks Family Foundation is investing $2.3 million to support Stemina Biomarker Discovery‘s clinical study of biomarkers in the blood of children with autism spectrum disorders (ASD), the foundation…
Exact Sciences announced this week that its Cologuard has won Popular Science magazine’s “Best of What’s New” Award. “Exact Sciences is honored to receive this recognition from the editors of…
Xylome announced today its licensing and equity agreements with the Wisconsin Alumni Research Foundation (WARF). According to a release, WARF will help Xylome develop and market unconventional yeasts that can transform biomass into sustainable…